Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised EQT IX in connection with sale of shares in Beijer Ref AB (publ) (1)
Mandate

Vinge has advised EQT IX in connection with sale of shares in Beijer Ref AB (publ)

September 18, 2024 Capital Markets and Public M&A

Vinge has advised EQT IX (”EQT”) in connection with the sale of shares in Beijer Ref AB (publ) through an accelerated bookbuilding process carried out on 17 September 2024.

In total, 20 million shares were placed at a price of SEK 165 per share, corresponding to a total value of SEK 3.3 billion.

Vinge’s team consisted of Sofie Bjärtun and Linnéa Sellström.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026